Free Trial
OTCMKTS:REMI

Remedent (REMI) Stock Price, News & Analysis

Remedent logo
$0.01 0.00 (0.00%)
As of 07/3/2025

About Remedent Stock (OTCMKTS:REMI)

Key Stats

Today's Range
$0.01
$0.01
50-Day Range
$0.01
$0.02
52-Week Range
$0.01
$0.07
Volume
N/A
Average Volume
80 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive REMI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Remedent and its competitors with MarketBeat's FREE daily newsletter.

REMI Stock News Headlines

Remedent (REMI) and Its Peers Head to Head Analysis
Head to Head Analysis: Remedent (REMI) vs. The Competition
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
REMYY Rémy Cointreau SA
Peterson Remy
See More Headlines

REMI Stock Analysis - Frequently Asked Questions

Remedent's stock was trading at $0.0550 at the start of the year. Since then, REMI shares have decreased by 81.8% and is now trading at $0.01.

Shares of REMI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Remedent investors own include AbbVie (ABBV), CoStar Group (CSGP), Enterprise Products Partners (EPD), Kellanova (K), Kandi Technologies Group (KNDI), MKS (MKSI) and M&T Bank (MTB).

Company Calendar

Today
7/07/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED/DENTAL - SUPP
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:REMI
Employees
4
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$990 thousand
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
-0.19

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (OTCMKTS:REMI) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners